Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug Dacarbazine
Autor: | Juliana Santos Rosa Viegas, Marcel Nani Leite, Maria Vitória Lopes Badra Bentley, Marco Andrey Cipriani Frade, Natália Aparecida de Paula, Fabíola Silva Garcia Praça, Leandra Naira Zambelli Ramalho |
---|---|
Rok vydání: | 2020 |
Předmět: |
Drug
Keratinocytes media_common.quotation_subject Dacarbazine Cell Pharmaceutical Science Human skin 02 engineering and technology Pharmacology 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine FIBROBLASTOS Medicine Distribution (pharmacology) Animals Humans media_common Skin integumentary system business.industry Melanoma Fibroblasts 021001 nanoscience & nanotechnology medicine.disease medicine.anatomical_structure Pharmaceutical Preparations 0210 nano-technology business Ex vivo Explant culture medicine.drug |
Zdroj: | Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP |
ISSN: | 1879-0720 |
Popis: | Alternative models to replace animals in experimental studies remain a challenge in testing the effectiveness of dermatologic and cosmetic drugs. We proposed a model of human organotypic skin explant culture (hOSEC) to assess the profile of cutaneous drug skin distribution, adopting dacarbazine as a model, and respective new methodologies for dermatokinetic analysis. The viability tests were evaluated in primary keratinocytes and fibroblasts, and skin by MTT and TTC assays, respectively. Then, dacarbazine was applied to the culture medium, and the hOSEC method was applied to verify the dynamics of skin distribution of dacarbazine and determine its dermatokinetic profile. The results of cell and tissue viability showed that both were considered viable. The dermatokinetic results indicated that dacarbazine can be absorbed through the skin, reaching a concentration of 36.36 µg/mL (18,18%) of the initial dose (200 µg/mL) after 12 h in culture. Histological data showed that the skin maintained its structure throughout the tested time that the hOSEC method was applied. No apoptotic cells were observed in the epidermal and dermal layers. No visible changes in the dermo-epidermal junction and no inflammatory processes with the recruitment of defense cells were observed. Hence, these findings suggest that the hOSEC concept as an alternative ex vivo model for assessing the dynamics of skin distribution of drugs, such as dacarbazine, and determining their respective dermatokinetic profiles. |
Databáze: | OpenAIRE |
Externí odkaz: |